Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity.
about
Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies.The revival of cancer vaccines - The eminent need to activate humoral immunity.Reply to Marchiò et al.: Antitumor immune regulation by angiostatic therapy.An antivascular vaccine to boost self-immunity and strike the tumorEvaluation of a xenogeneic vascular endothelial growth factor-2 vaccine in two preclinical metastatic tumor models in mice.Design, crystal structure and atomic force microscopy study of thioether ligated d,l-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa.
P2860
Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeted vaccination against t ...... efficient antitumor activity.
@en
Targeted vaccination against t ...... efficient antitumor activity.
@nl
type
label
Targeted vaccination against t ...... efficient antitumor activity.
@en
Targeted vaccination against t ...... efficient antitumor activity.
@nl
prefLabel
Targeted vaccination against t ...... efficient antitumor activity.
@en
Targeted vaccination against t ...... efficient antitumor activity.
@nl
P2093
P2860
P356
P1476
Targeted vaccination against t ...... efficient antitumor activity.
@en
P2093
Arjan W Griffioen
Daniele Altschuh
Klaus Schwamborn
Peter Timmerman
Rob H Meloen
Sebastien P Tabruyn
Teun Schuurman
Tilman M Hackeng
Wouter C Puijk
P2860
P304
12532-12537
P356
10.1073/PNAS.1610258113
P407
P577
2016-10-17T00:00:00Z